atrial fibrillation Clinical Trials and Research
Also known as: afib, af, auricular fibrillation, irregular heartbeat, paroxysmal atrial fibrillation, persistent atrial fibrillation · ICD-10: I48
Atrial fibrillation (AFib) is a common heart condition causing an irregular and often rapid heartbeat. Clinical trial research aims to develop new ways to prevent strokes, manage symptoms, and improve long-term outcomes for patients. Find a Trial helps patients search for active studies.
Search atrial fibrillation trials →
Common questions about atrial fibrillation clinical trials
Who can participate in atrial fibrillation clinical trials?
Eligibility criteria vary by study, often including age, AFib type, and overall health. Researchers use these criteria to ensure patient safety and collect relevant data. Information is available on ClinicalTrials.gov, detailing specific requirements for each study.
What are the different phases of clinical trials for AFib?
Clinical trials typically progress through phases, from early-stage safety tests (Phase 1) to larger studies evaluating effectiveness and comparing new treatments (Phases 2 and 3). Phase 4 studies monitor long-term effects once a treatment is approved.
Do clinical trials for atrial fibrillation cost money to participate?
Generally, study-related medical care and interventions in clinical trials are covered by the trial sponsor. However, other healthcare costs or travel expenses may not be. Patients should discuss all potential costs with the research team before enrolling.
What are current research directions in atrial fibrillation clinical trials?
Current research focuses on novel antiarrhythmic drugs, improved ablation techniques, and devices for stroke prevention. Scientists are also investigating genetic factors and personalized treatment approaches, according to data from NIH RePORTER and ClinicalTrials.gov.
What types of interventions are studied in AFib clinical trials?
Studies often evaluate new medications to control heart rhythm or rate, catheter ablation procedures, and implantable devices like left atrial appendage occluders. Lifestyle interventions and digital health tools are also explored to improve patient management.
Are there specific biomarkers relevant to AFib clinical trials?
Researchers are investigating biomarkers such as natriuretic peptides, inflammatory markers, and genetic variants to predict AFib risk, progression, and treatment response. These can help identify patients who might benefit most from certain interventions, as seen on ClinicalTrials.gov.
What might prevent someone from joining an AFib clinical trial?
Common exclusion criteria can include other serious heart conditions, recent stroke, severe kidney or liver disease, or pregnancy. These are in place to protect participants and ensure study results are clear and applicable to the target population.
How do AFib clinical trials address stroke prevention?
Many AFib trials focus on preventing stroke, a major complication. This includes evaluating new blood thinners, left atrial appendage occlusion devices, and strategies to identify high-risk patients. Data is available on ClinicalTrials.gov and NIH RePORTER.
How to find a atrial fibrillation trial that fits you
- Describe your atrial fibrillation situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all atrial fibrillation trials →